chrisvoncsefalvay/vaers-outcomes huggingface dataset:
MMR given 02/06/04 fever, body aches, chills started 2/15/04. Fever broke 2/17/04. Rash began 2/18/04 (diffuse erythemic papular) over head & neck. Macular rash over trunk & arms. 2/21/04 rash gone.
has a pinched nerve in her neck.; This is a spontaneous report received from a Pfizer-sponsored program. A contactable consumer reported for herself, a female patient of an unspecified age who received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date unknown), via an unspecified route of administration on 13Mar2021 as first dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had vaccine a few hours ago and has a pinched nerve in her neck on 13Mar2021. She was wondering if and when she can take a pain reliver. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pain in arm; Soreness and discomfort in arm at site of injection; Soreness and discomfort in arm at site of injection; This spontaneous report was received from a nurse prescriber, referring to a 41 year old female patient. The patient had no pertinent medical history and was not taking any concomitant medication.  On 21-JUL-2021, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 0.5 milliliter, intramuscularly, lot # T028583 (expiration date not provided, but upon internal validation established as 04-MAR-2023) for prevention of human papilloma virus.   On the same day, the patient experienced soreness and discomfort in the arm at site of vaccination. Additionally, per the reporting nurse, the patient's only complaint was pain in arm. The patient sought for medical attention and the reporting nurse denied redness or swelling; however, the patient started treatment with over the counter non-steroidal antiinflammatory drugs (NSAIDS) for the events. No laboratory diagnostic tests or studies were performed, and no intervention to prevent serious criteria was reported.  At the time of the report, the patient had not recovered from the events.  The reporter's causality assessment between the event's and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was unknown. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T028583; expirationdate: 04-MAR-2023; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent
Seen at hosp ER on 4/13/03 for increased temp/swelling and redness of L upper arm-docemented temp upon admission of 103.4. Dx with cellulitis L deltoid by ER MD and placed on Keflex PO. As of 4/14/03 still had high temp (103-104) and advised by PMD to return to ER. Mother states child improving will see PMD at office.
Severe diarrhea, extreme abdominal gas and bloating, this caused a pause in radiation treatments, nausea, chills, insomnia, cognitive impairment
Vomiting 4 times after feeling nauseous and weak with head and body aches for 2 days
Confused and scattered. Possibly light headed. Client stated she is on many medications - XANAX was only one named. Has been seen @ health clinic. Hx suicide attempts. Initial Sx happened after vaccine - per client. Called the next day to report.
Second day, red rash, chest, back and sides 1-week. Caladryl-several time a day.
Patient stated that rash began approximately 2 hours after the administration of the vaccine. Patient went to the hospital where Prednisone and Diphenhydramine were administered. Patient stated that the rash cleared up. On 07/21/2020 at around bedtime, patient stated that the itching began again. Patient was seen in our office 07/22/2020 for ER f/u and was prescribed Prednisone, Epi-pen, and Cetirizine.
Symptoms started approximately 23 hours after my first Pfizer dose.  I had a visual disturbance that lasted ten minutes.  First my vision went blurry at the edges, then I saw flashes of light and eventually I saw a zigzag pattern across my vision.  Since this happened the left side of my face primarily above and below my eye has been tingly and numb feeling, as well as slightly swollen.  I have also had vertigo for 11 days now that is getting worse instead of better.
Chills, fever 104.2, Nausea began at 2:30 AM 11/07 x 3 days - 101.4 x 1 day - 99.3 x 2-3 days - Pain, swelling, fever, knot at injection site 1-2 wks Joint pain - worse (L) elbow. felt like bone splitting x 1-2 wks. More Symptoms - Severe pain thru (L) shoulder into Back Appx 3 days - Used Heat & Biofreeze. Enlarged lymph nodes (L) axillary 1 wk - & (L) Breast still have at first uses moist warm compresses - then Ice Packs. Eyes sore - feels like pressure behind eyeballs. Still have some pressure behind (L) eyeball. Red Raised Rash - itching - Took Zyrtec, Benadryl - lasted Appx 1 wk. Notified Health Dept. to See if had other people with Symptoms. She Notified Dr. - Then he said he would call CDC before he gave me an answer. Was Notified back by Health Dept. & said CDC said it was a Rare Reaction to one of the Preservatives in the Moderna. Advised to Never take any more of Moderna. Advised to use Ice Packs. Took Zofran for Nausea - Alternate Ibuprofen & Tylenol for fever. Symptoms got Severe at appx 2:30 AM - 11/07/21. Had few chills appx. 1 hr. after injection. The 2nd Moderna shot I had similar symptoms - Not as severe. Had chills, fever 103.7, Nausea, Sore Arm. Symptoms improved on 3rd DAy.
sore arm on the injection site where vaccine was administered; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team for a Pfizer sponsored program (159558).  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm, administration date Apr2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. Relevant medical history included: "kidney transplant", start date: Feb2021, stop date: Feb2021, notes: way back February, before getting the 1st dose of the vaccine. The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "sore arm on the injection site where vaccine was administered". Additional information: The patient received the second dose about two weeks ago (at the time of report).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever w/in 24 hrs of vax -> febrile seizure. F/u exam c/w Coxsackie infection.
First woke with flu like symptoms, with small fever, next day woke up with left foot swollen, abdomen swollen, vomiting and diarrhea, inside of mouth swollen, throat swollen.
PT REQUESTED MODERNA BIVALENT, BUT WAS GIVE PFIZER BIVALENT INSTEAD.
This spontaneous report was received from a registered nurse referring to a patient of currently 63 years of age and unspecified gender. The patient's pertinent medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored dose of ZOSTAVAX, lot # L027322, expiry date unspecified (dose, route of administration and anatomical location not reported). The doses of ZOSTAVAX was involved in temperature incident. This is one of several reports from the same reporter. Additional information has been requested.
itching & warmth @ site of inj, pt called MD 8FEB96;allergy to tetanus, given DPh
Extreme itching of entire body; Swollen face and throat; Swollen face and throat; entire body slightly puffy; hives on back; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 28Apr2021 at 17:30(at the age of 21-year-old) as a single dose for COVID-19 immunisation. Medical history included ADHD, depression and anxiety. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and depression meds; both from unknown date for unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 17:30 (at the age of 21-years-old) as a single dose for COVID-19 immunisation and Penicillin on an unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 20:30 after 3 hours of vaccination, the patient experienced Extreme itching of entire body, Swollen face and throat, entire body slightly puffy and hives on back. Therapeutic measures were taken as a result of the reported events and included treatment herself with Ibuprofen but hadn't helped yet. The clinical outcome of the Extreme itching of entire body, Swollen face and throat, entire body slightly puffy and hives on back was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
pt recv vax 5OCT98 & had a slight swollen arm, rt deltoid area;c/o pain but went to school, vomited;felt feverish, rt deltoid area was red, hot & more swollen;c/o minimal discomfort; rt deltoid red/swollen;
sub-q tissue to R deltoid area remains reddened, swollen and warm to the touch.  Injection site is firm.  Resident reports area is painful to the touch.  Area measures approximately 5" x 5".  Resident is morbidly obese with excessive adipose tissue to upper arms.  Staff applying cool compresses throughout the day, and administering Tylenol for comfort.
Next morning had chills; Aching; Vomited; Day of vaccine sore arm; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 07May2021 at 16:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included mild asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 16Apr2021 at 16:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 07May2021, on the day of vaccination, the patient experienced sore arm. On 08May2021 at 07:00, when the patient woke up next morning, the patient experienced chills, aching and vomited. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events day of vaccine sore arm, and the patient woke up with chills, aching and vomited was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
I woke up with chills and fever 12.5 hours after the vaccine. Fever lasted for 36 hours and went as high as 102.4. Intermittent nausea and very tired.
Fever of 102 degrees F (baseline temperature is usually around 97.3 degrees F). Extreme fatigue, chills + hot flashes, and muscle aches. Completely unable to work or perform regular activities -- essentially bedridden for 24 hours.
Pfizer on 3/1 and 3/22. Positive on 9/4 admitted 9/4 to current
deep phlegmy cough/ the phlegm is now green; deep phlegmy cough/ the phlegm is now green; sore throat; a fever ranging from 100-102; Severe chills; headache; tired; feeling lousy; This is a spontaneous report from a contactable consumer. A 40-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot unknown, first dose) solution for injection intramuscular on 30Mar2021 at 16:45 (at the age of 40-years-old) as a single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. On 31Mar2021, the patient experienced a fever ranging from 100-102 F (fever lasting more than a week), severe chills, and headache. In Mar2021, the patient was tired and feeling lousy. On 02Apr2021, the patient developed deep phlegmy cough/ the phlegm was now green, and sore throat. There was no emergency room or physician office visit. Treatment for the events fever, headache, sore throat, tired and feeling lousy included acetaminophen (TYLENOL). There was no treatment for the events chills and phlegmy cough/phlegm was now green. The outcome of the events fever, chills, deep phlegmy cough/phlegm was now green, and sore throat was not recovered. The outcome of the event headache was recovered on 03Apr2021. The outcome of the events tired and feeling lousy was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Moderna COVID-19 Vaccine . Injection simple no issue, 11 pm developed slight sinus pressure. Slight upper chest and shoulder muscle and joint ache. Slight muscle/joint ache spread overall thereafter with mild fever. Awoke when fever broke at 3:40 am. Slept to 7 am and got up to go shower. Unsteady and lightheaded, residual aches almost gone. Could not stand in shower so sat down, then fell asleep for a few minutes, awoke still lightheaded so got back to bed and slept until 10 am. Awoke feeling much better. Aches gone, sinus fine, low energy. Rested for the day. Slept normally that night. Following morning all symptoms gone. Normal.
PT had myocarditis as a result of the second dose of the vaccine.  He spent 5 days at Hospital.
One week later, location of shot has gotten warm, itchy and swollen, making the skin feel lumpy. Body is now slightly feverish, too, 12 hours after the symptoms on my arm. It has currently been about 12 hours since really noticing these affects.
covid test result=Positive / covid test date=10Jan2022; covid test result=Positive / covid test date=10Jan2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34 year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 09Jan2022 12:00 (Lot number: FL3198) at the age of 34 years as dose 2, single and administered in arm left, administration date 19Dec2021 12:00 (Lot number: FE3594) at the age of 34 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Fibromyalgia" (unspecified if ongoing). Concomitant medication(s) included: GABAPENTIN; AMITRIPTYLINE; TYLENOL; OMEPRAZOLE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 10Jan2022 04:00, outcome "unknown" and all described as "covid test result=Positive / covid test date=10Jan2022". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (10Jan2022) positive.
Initial unsolicited case received from a nurse on 31 Jul 2017. This case involves 42-years-old female patient who was vaccinated with dose one of IMOVAX, and a dose of IMMUNOGLOBULINS (Manufacturer also reported as unknown) (Batch number, expiry date, dose, route, and site of administration were not reported for both vaccines) on 24 Jul 2017, and dose two of IMOVAX (Batch number: M131142M, expiry date, dose not reported, site of administration unknown) via intramuscularly on 27 Jul 2017. The patient illness at the time of vaccination was unknown, and the patient had sulfa allergy. Concomitant medications were not reported. On 31 Jul 2017, seven days after the vaccination with first dose of IMOVAX, and immunoglobulins, and four days after the second dose of IMOVAX, the patient had developed muscle twitches and pins and needles in her legs. It was reported as the patient required to visit doctor and ER (emergency room). The patient relevant lab tests and corrective treatment were not reported. As of 31 Jul 2017, the patient was not recovered from the events. List of documents held by sender: none.
pain under my tongue on the right side; canker sore formed in the same area / another canker sore formed on the left under side of my tongue a few days after that, as well as sores on the inside of my cheeks; sores were very painful and made it difficult to eat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 02Apr2021 (Lot number: EP6955) at the age of 27 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "PCOS" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing). Concomitant medication(s) included: JUNEL FE 1/20. Vaccination history included: Bnt162b2 (1st dose, lot number: EN6202, vaccine location: left arm), administration date: 12Mar2021, when the patient was 26 years old, for Covid-19 immunisation, reaction(s): "pain under my tongue". The following information was reported: GLOSSODYNIA (non-serious) with onset 06Apr2021, outcome "recovering", described as "pain under my tongue on the right side"; APHTHOUS ULCER (non-serious) with onset 06Apr2021, outcome "recovering", described as "canker sore formed in the same area / another canker sore formed on the left under side of my tongue a few days after that, as well as sores on the inside of my cheeks"; PAIN (non-serious) with onset 06Apr2021, outcome "recovering", described as "sores were very painful and made it difficult to eat". The events "pain under my tongue on the right side", "canker sore formed in the same area / another canker sore formed on the left under side of my tongue a few days after that, as well as sores on the inside of my cheeks" and "sores were very painful and made it difficult to eat" were evaluated at the physician office visit. Therapeutic measures were taken as a result of glossodynia, aphthous ulcer, pain.  Additional information: The patient did not receive any other vaccines within 4 week prior vaccination. The patient had not been diagnosed with COVID-19 prior vaccination and had not been tested for COVID-19 since vaccination. The patient had steroid (dexamethasone) swish and spit to help speed up the healing process.   No follow-up attempts are possible. No further information is expected.
Patient states she has raised red hive-like rash on her trunk area (stomach, back, arm pits, breasts).  The rash itches.  She asked if rash could be related to the flu vaccine, as she has had flu vaccines many years previously.  She also had one of her "allergy injections" the day following the flu vaccine.  She reported to me on 10/01/2012 around 3:00 PM, and had not treated the rash.  She will take Benadryl.  I told her to have the doctor look at the rash in case it is not an allergy.
Nightly Lucid Dreams, disrupted sleep.  1-2 dreams per night, and usually awaken by the end of the dream.  No other reaction whatsoever to the vaccine.
Two days subsequent to receiving one dose of Engerix B, (11/18/1999) the pt experienced injection site swelling, pain and blister. Additionally she developed a low grade fever, body aching, diarrhea, nausea, dizziness and decreased appetite. On 11/22/1999 the swollen area became red and inflamed and moved toward the axilla. The pt was treated with antihistamines, Tylenol with codeine, ice and moist heat. An infectious disease specialist stated that the pt had experiences a systemic reaction. As of 01/11/2000 the pt continues to have recurrent symptoms every two weeks. She was seen by an infectious disease specialist who had a culture and biopsy of the arm performed. There were no reports from the specialist as of yet. The mother reported that the biopsy showed only inflammation and allergic response. The pt has been treated with prednisone which has not helped much. The most recent information received reports the condition of the pt is ongoing.
Information has been received on 15-FEB-2019 regarding a case in litigation concerning a 71 year old female patient. The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient was prescribed ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. In 2015, the patient was administered the ZOSTAVAX by a pharmacist. In 2017, the patient was treated by a physician for shingles as a result of her vaccination with ZOSTAVAX. The outcome was not provided. Additional information has been requested.
3/19/2021   Patient was observed post Covid-19 immunization for 30 minutes based on pre-vaccination screening .  During the observation period, she experienced an adverse reaction with the following symptoms:  . BLURIED VISION Assessment : Time of assessment . 1034AM   Actions taken:      VS TAKEN, BP-130/89, HR-72, O2 100%, WATER OFFERED AND DRINKING, ENCOURAGED TO EAT AS SHE VOICES THAT SHE HAS NOT HAD FOOD TODAY, HAD DRIVER WITH HER.   Medications administered: No medication administered.   Disposition: Reports no further symptoms of adverse reaction after observation for . minutes. Discharged home. Instructed to call 911 for trouble breathing, rapid heart rate, dizziness, swelling of tongue or throat.     Immunizations Administered    Name Date Dose VIS Date Route   Pfizer COVID-19 Vaccine 3/19/2021 10:00 AM 0.3 mL 12/11/2020 Intramuscular
Vaccine taken at 10:40 AM.  Fatigue within 30 minutes.  Fever, muscle aches, headache, cough, chest congestion, and sore throat began at approximately 3:30 PM.  Left eye became very red, itchy, and swollen at about 8 PM.  None of these symptoms were present before the vaccination.  Treated fever with Tylenol.  Treated eye symptoms with Elestat.
redness around the shot; This case was reported by a consumer via interactive digital media and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The reporter asked about how long does the redness around the shot last.
patient received 2 IMZ.  Patient fainted after the 2nd IMZ. Patients partner said that he faints all the time when receiving IMZ due to anxiety. Partner was ready to hold him up after pt said "that hurt" and was not concerned. Patient was unconscious for approx 30 seconds.  I asked if they wanted me to call anyone and they declined. Patient sat in IMZ room for about 5 min, then walked out .
presented to ER w/gen arthralgia, h/a, fever, nausea, vomiting, diarrhea, confusion, disorientation;adm hosp;dx serum sickness;
Day 8 post-vaccine developed rash and itching on anterior part arm which have lasted 3+ days. Location of new symptoms same place as where initially had pain post-vaccine which lasted approx 48 hours following vaccine and then subsided.
HEADACHE AND LIGHTHEADED (NO TREATMENT ) STARTED ABOUT 5 MINUTES AFTER THE DOSE AND LASTED FOR 2-3 DAYS